Mechanistic Investigation of Therapies for Down Syndrome Regression Disorder
Latest Information Update: 26 Mar 2024
At a glance
- Drugs Immune globulin (Primary) ; Lorazepam (Primary) ; Tofacitinib (Primary)
 - Indications Down syndrome
 - Focus Adverse reactions
 
Most Recent Events
- 25 Jan 2023 Status changed from not yet recruiting to recruiting, according to a Childrens Hospital Los Angeles media release.
 - 25 Jan 2023 According to a Childrens Hospital Los Angeles media release, Children's Hospital Los Angeles (CHLA) has launched this trial and trial is funded by a five-year, 5.3 million dollar grant from the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute for Child Health and Human Development.
 - 23 Dec 2022 New trial record